BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18267280)

  • 1. Stage-dependent patterns of disturbed neural synchrony in Parkinson's disease.
    Berendse HW; Stam CJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S440-5. PubMed ID: 18267280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: an MEG study.
    Stoffers D; Bosboom JL; Deijen JB; Wolters ECh; Stam CJ; Berendse HW
    Neuroimage; 2008 Jun; 41(2):212-22. PubMed ID: 18395468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology.
    Uhlhaas PJ; Singer W
    Neuron; 2006 Oct; 52(1):155-68. PubMed ID: 17015233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders.
    Stam CJ
    J Neurol Sci; 2010 Feb; 289(1-2):128-34. PubMed ID: 19729174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowing of M1 activity in Parkinson's disease during rest and movement--an MEG study.
    Vardy AN; van Wegen EE; Kwakkel G; Berendse HW; Beek PJ; Daffertshofer A
    Clin Neurophysiol; 2011 Apr; 122(4):789-95. PubMed ID: 21109487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal study of event-related desynchronization in idiopathic Parkinson's disease.
    Defebvre L; Derambure P; Bourriez JL; Jacquesson JM; Dujardin K; Destée A; Guieu JD
    Adv Neurol; 1993; 60():422-8. PubMed ID: 8420166
    [No Abstract]   [Full Text] [Related]  

  • 7. Disrupted brain network topology in Parkinson's disease: a longitudinal magnetoencephalography study.
    Olde Dubbelink KT; Hillebrand A; Stoffers D; Deijen JB; Twisk JW; Stam CJ; Berendse HW
    Brain; 2014 Jan; 137(Pt 1):197-207. PubMed ID: 24271324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological cerebral oscillatory activity in Parkinson's disease: a critical review on methods, data and hypotheses.
    Timmermann L; Florin E; Reck C
    Expert Rev Med Devices; 2007 Sep; 4(5):651-61. PubMed ID: 17850199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ
    Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
    [No Abstract]   [Full Text] [Related]  

  • 10. Deficient "sensory" beta synchronization in Parkinson's disease.
    Degardin A; Houdayer E; Bourriez JL; Destée A; Defebvre L; Derambure P; Devos D
    Clin Neurophysiol; 2009 Mar; 120(3):636-42. PubMed ID: 19208497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology.
    Bartels AL; Leenders KL
    Cortex; 2009 Sep; 45(8):915-21. PubMed ID: 19095226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neural network model of Parkinson's disease bradykinesia.
    Cutsuridis V; Perantonis S
    Neural Netw; 2006 May; 19(4):354-74. PubMed ID: 16359844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlinear dynamical analysis of EEG and MEG: review of an emerging field.
    Stam CJ
    Clin Neurophysiol; 2005 Oct; 116(10):2266-301. PubMed ID: 16115797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondopaminergic neurons in Parkinson's disease.
    Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
    Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
    [No Abstract]   [Full Text] [Related]  

  • 15. Minor depression and brain perfusion images in Parkinson's disease.
    Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
    Mov Disord; 2006 Aug; 21(8):1169-74. PubMed ID: 16685687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow brain potential and oscillatory EEG manifestations of impaired temporal preparation in Parkinson's disease.
    Praamstra P; Pope P
    J Neurophysiol; 2007 Nov; 98(5):2848-57. PubMed ID: 17728390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic modulation of cortico-cortical functional connectivity in Parkinson's disease: an MEG study.
    Stoffers D; Bosboom JL; Wolters ECh; Stam CJ; Berendse HW
    Exp Neurol; 2008 Sep; 213(1):191-5. PubMed ID: 18590728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-frequency MEG activity and MRI evaluation in Parkinson's disease.
    Kotini A; Anninos P; Adamopoulos A; Prassopoulos P
    Brain Topogr; 2005; 18(1):59-63. PubMed ID: 16193267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and pathophysiology of the basal ganglia-thalamo-cortical networks.
    Rosin B; Nevet A; Elias S; Rivlin-Etzion M; Israel Z; Bergman H
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S437-9. PubMed ID: 18267279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.